Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 392

1.

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.

Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT.

Thorax. 2003 May;58(5):377-82.

2.

[CCERW: a new rule to predict treatment failure in patients with community-acquired pneumonia in middle aged and elderly people].

Li JS, Li SY, Yu XQ, Sun ZK, Zhang W, Jia XH, Zheng SP, Wang MH, Wang HF.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Jan;23(1):10-7. Chinese.

3.

Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia.

España PP, Capelastegui A, Quintana JM, Bilbao A, Diez R, Pascual S, Esteban C, Zalacaín R, Menendez R, Torres A.

J Infect. 2010 Feb;60(2):106-13. doi: 10.1016/j.jinf.2009.11.013. Epub 2009 Dec 2. Review.

PMID:
19961875
4.

Predicting mortality among older adults hospitalized for community-acquired pneumonia: an enhanced confusion, urea, respiratory rate and blood pressure score compared with pneumonia severity index.

Abisheganaden J, Ding YY, Chong WF, Heng BH, Lim TK.

Respirology. 2012 Aug;17(6):969-75. doi: 10.1111/j.1440-1843.2012.02183.x.

PMID:
22574694
5.

[Development of an instrument to assess the severity of community acquired pneumonia among hospitalized patients].

Saldías F, Farías G, Villarroel L, Valdivia G, Mardónez JM, Díaz A.

Rev Med Chil. 2004 Sep;132(9):1037-46. Spanish.

PMID:
15543759
6.

Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.

Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, Graff LG, Fine JM, Fine MJ.

Am J Med. 2005 Apr;118(4):384-92.

PMID:
15808136
7.

Community acquired pneumonia: aetiology and usefulness of severity criteria on admission.

Neill AM, Martin IR, Weir R, Anderson R, Chereshsky A, Epton MJ, Jackson R, Schousboe M, Frampton C, Hutton S, Chambers ST, Town GI.

Thorax. 1996 Oct;51(10):1010-6.

8.

SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia.

Charles PG, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M; Australian Community-Acquired Pneumonia Study Collaboration, Grayson ML.

Clin Infect Dis. 2008 Aug 1;47(3):375-84. doi: 10.1086/589754.

PMID:
18558884
9.

Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia.

Capelastegui A, España PP, Quintana JM, Bilbao A, Menendez R, Zalacain R, Torres A.

Thorax. 2009 Jun;64(6):496-501. doi: 10.1136/thx.2008.098814. Epub 2009 Feb 22.

PMID:
19237392
10.

Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia.

Chalmers JD, Singanayagam A, Hill AT.

Thorax. 2008 Aug;63(8):698-702. doi: 10.1136/thx.2008.095562. Epub 2008 May 20.

PMID:
18492742
11.

Validation of predictive rules and indices of severity for community acquired pneumonia.

Ewig S, de Roux A, Bauer T, García E, Mensa J, Niederman M, Torres A.

Thorax. 2004 May;59(5):421-7.

12.

A prognostic rule for elderly patients admitted with community-acquired pneumonia.

Conte HA, Chen YT, Mehal W, Scinto JD, Quagliarello VJ.

Am J Med. 1999 Jan;106(1):20-8.

PMID:
10320113
13.

Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool.

Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, Brown GV.

Emerg Med Australas. 2007 Oct;19(5):418-26.

PMID:
17919214
14.

Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.

Chalmers JD, Singanayagam A, Murray MP, Scally C, Fawzi A, Hill AT.

Thorax. 2009 Jul;64(7):592-7. doi: 10.1136/thx.2008.105080. Epub 2009 Jan 8.

PMID:
19131449
15.

Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?

Kelly E, MacRedmond RE, Cullen G, Greene CM, McElvaney NG, O'Neill SJ.

Respirology. 2009 Mar;14(2):210-6. doi: 10.1111/j.1440-1843.2008.01423.x.

PMID:
19272082
16.

Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia.

Hoogewerf M, Oosterheert JJ, Hak E, Hoepelman IM, Bonten MJ.

Clin Microbiol Infect. 2006 Nov;12(11):1097-104.

17.

Assessment of severity of community-acquired pneumonia.

Boersma WG.

Semin Respir Infect. 1999 Jun;14(2):103-14. Review.

PMID:
10391405
18.

Severity prediction rules in community acquired pneumonia: a validation study.

Lim WS, Lewis S, Macfarlane JT.

Thorax. 2000 Mar;55(3):219-23.

19.

Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database.

Fine MJ, Singer DE, Hanusa BH, Lave JR, Kapoor WN.

Am J Med. 1993 Feb;94(2):153-9.

PMID:
8430711
20.

Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission.

Liapikou A, Ferrer M, Polverino E, Balasso V, Esperatti M, Piñer R, Mensa J, Luque N, Ewig S, Menendez R, Niederman MS, Torres A.

Clin Infect Dis. 2009 Feb 15;48(4):377-85. doi: 10.1086/596307.

PMID:
19140759

Supplemental Content

Support Center